investorscraft@gmail.com

Intrinsic Value of Corteva, Inc. (CTVA)

Previous Close$73.57
Intrinsic Value
Upside potential
Previous Close
$73.57

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Corteva, Inc. operates as a leading global pure-play agriculture company, specializing in seed and crop protection solutions. The company serves farmers worldwide with innovative products designed to enhance yield, resilience, and sustainability. Corteva’s revenue model is driven by seed sales, which include proprietary hybrid and genetically modified seeds, and crop protection chemicals such as herbicides, insecticides, and fungicides. The company operates in a highly competitive sector dominated by large agribusiness players, where technological innovation and regulatory compliance are critical. Corteva’s market position is strengthened by its extensive R&D capabilities, global distribution network, and strong brand recognition. The agriculture industry faces challenges from climate change and shifting regulatory landscapes, but Corteva’s focus on sustainable solutions positions it to capitalize on long-term demand for efficient farming inputs. Its diversified portfolio across geographies and crop types mitigates regional risks while supporting steady growth.

Revenue Profitability And Efficiency

Corteva reported revenue of $16.9 billion for FY 2024, with net income of $907 million, reflecting a net margin of approximately 5.4%. Diluted EPS stood at $1.30, supported by disciplined cost management. Operating cash flow was robust at $2.15 billion, though capital expenditures of $597 million indicate ongoing investments in production and R&D. The company’s ability to convert revenue into cash underscores operational efficiency.

Earnings Power And Capital Efficiency

Corteva’s earnings power is anchored in its high-margin seed business and scalable crop protection portfolio. The company’s capital efficiency is evident in its ability to generate substantial operating cash flow relative to capital expenditures. With $3.11 billion in cash and equivalents, Corteva maintains flexibility for strategic investments, share repurchases, or debt reduction, balancing growth and shareholder returns.

Balance Sheet And Financial Health

Corteva’s balance sheet remains solid, with $3.11 billion in cash and equivalents against total debt of $2.70 billion, indicating a conservative leverage profile. The company’s liquidity position is strong, providing resilience against cyclical downturns in agriculture. Shareholders’ equity is bolstered by retained earnings, reflecting prudent financial management and a focus on sustainable growth.

Growth Trends And Dividend Policy

Corteva’s growth is driven by demand for advanced agricultural technologies and expansion in emerging markets. The company paid a dividend of $0.66 per share, signaling a commitment to returning capital to shareholders. While dividend yields remain modest, Corteva’s focus on reinvestment for long-term growth aligns with industry trends favoring innovation over high payouts.

Valuation And Market Expectations

Corteva’s valuation reflects its position as a key player in the agribusiness sector, trading at a premium to peers with similar growth profiles. Market expectations are tied to its ability to sustain innovation and margin expansion, particularly in high-growth regions. Investor sentiment remains cautiously optimistic, balancing near-term cyclical risks with long-term structural demand for agricultural solutions.

Strategic Advantages And Outlook

Corteva’s strategic advantages include its R&D leadership, global scale, and diversified product portfolio. The company is well-positioned to benefit from trends in precision agriculture and sustainability. Near-term challenges include input cost volatility and regulatory scrutiny, but Corteva’s focus on innovation and operational efficiency supports a positive long-term outlook.

Sources

Company filings (10-K), investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount